Torrent Historical Balance Sheet

TORNTPHARM

3,324 121.25 3.79%

Trend analysis of Torrent Pharmaceuticals Limited balance sheet accounts such as Total Stockholder Equity of 72 B, Property Plant And Equipment Net of 20.1 B, Net Debt of 22.3 B or Retained Earnings of 41.4 B provides information on Torrent Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Torrent Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Torrent Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Torrent Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Torrent Pharmaceuticals is a good buy for the upcoming year.

Torrent Pharmaceuticals Inventory

13.26 Billion

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Torrent Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Torrent Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Torrent Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Torrent Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Torrent Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Torrent currently owns. An asset can also be divided into two categories, current and non-current.

Torrent Pharmaceuticals Balance Sheet Chart

As of now, Torrent Pharmaceuticals' Non Currrent Assets Other are increasing as compared to previous years. The Torrent Pharmaceuticals' current Other Current Assets is estimated to increase to about 8.4 B, while Total Assets are projected to decrease to under 81.8 B.

Total Assets Short Long Term Debt Total Other Current Liab Capital Surpluse Net Working Capital

Add Fundamental

Total Assets

Total assets refers to the total amount of Torrent Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Torrent Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most accounts from Torrent Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Torrent Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Torrent Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	40.7B	53.7B	40.2B	27.1B
Total Assets	131.0B	150.1B	150.6B	81.8B

Short Long Term Debt Total Total Assets

Torrent Pharmaceuticals balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Short Term Investments	Intangible Assets	Current Deferred Revenue	Short Term Debt
Total Assets		0.94	0.66	0.99	0.84	0.98	0.92	0.67	0.18	0.91	0.22	0.4	0.87	0.2	0.93	0.95	0.45	-0.21	0.98	0.93	0.59	0.85	0.28	0.96	0.02	0.88
Short Long Term Debt Total	0.94		0.62	0.95	0.72	0.9	0.99	0.52	0.04	0.89	0.14	0.3	0.77	0.04	0.97	0.85	0.42	-0.31	0.98	0.81	0.44	0.77	0.26	0.97	-0.04	0.91
Other Current Liab	0.66	0.62		0.65	0.53	0.68	0.6	0.33	0.23	0.58	0.28	0.38	0.54	0.22	0.66	0.68	0.57	-0.06	0.67	0.68	0.14	0.7	0.24	0.57	-0.14	0.47
Total Current Liabilities	0.99	0.95	0.65		0.81	0.97	0.92	0.65	0.26	0.9	0.17	0.37	0.87	0.2	0.92	0.94	0.43	-0.19	0.99	0.91	0.58	0.85	0.21	0.96	-0.05	0.9
Total Stockholder Equity	0.84	0.72	0.53	0.81		0.86	0.7	0.94	0.15	0.94	0.3	0.27	0.72	0.53	0.7	0.85	0.36	0.15	0.78	0.79	0.83	0.68	0.13	0.81	0.03	0.8
Property Plant And Equipment Net	0.98	0.9	0.68	0.97	0.86		0.87	0.7	0.24	0.9	0.12	0.31	0.85	0.21	0.87	0.98	0.48	-0.21	0.95	0.91	0.57	0.81	0.17	0.92	-0.04	0.88
Net Debt	0.92	0.99	0.6	0.92	0.7	0.87		0.49	-0.06	0.88	0.16	0.28	0.73	0.01	0.97	0.83	0.43	-0.35	0.96	0.78	0.41	0.73	0.3	0.96	-0.01	0.89
Retained Earnings	0.67	0.52	0.33	0.65	0.94	0.7	0.49		0.24	0.83	0.18	0.1	0.59	0.67	0.47	0.7	0.18	0.36	0.58	0.6	0.89	0.48	-0.09	0.65	0.02	0.7
Cash	0.18	0.04	0.23	0.26	0.15	0.24	-0.06	0.24		0.1	-0.22	0.18	0.37	0.31	0.03	0.21	-0.07	0.38	0.16	0.28	0.31	0.38	-0.36	0.05	-0.22	0.11
Non Current Assets Total	0.91	0.89	0.58	0.9	0.94	0.9	0.88	0.83	0.1		0.22	0.24	0.74	0.4	0.85	0.86	0.36	0.01	0.9	0.78	0.74	0.72	0.13	0.93	-0.05	0.92
Non Currrent Assets Other	0.22	0.14	0.28	0.17	0.3	0.12	0.16	0.18	-0.22	0.22		0.77	0.18	0.3	0.29	0.1	0.27	0.13	0.23	0.4	0.31	0.4	0.82	0.15	0.15	-0.05
Cash And Short Term Investments	0.4	0.3	0.38	0.37	0.27	0.31	0.28	0.1	0.18	0.24	0.77		0.37	0.02	0.47	0.28	0.3	-0.11	0.42	0.62	0.25	0.65	0.85	0.25	0.29	0.02
Net Receivables	0.87	0.77	0.54	0.87	0.72	0.85	0.73	0.59	0.37	0.74	0.18	0.37		0.11	0.8	0.85	0.46	-0.1	0.86	0.9	0.55	0.89	0.16	0.77	-0.05	0.69
Common Stock Shares Outstanding	0.2	0.04	0.22	0.2	0.53	0.21	0.01	0.67	0.31	0.4	0.3	0.02	0.11		0.01	0.17	-0.21	0.81	0.12	0.15	0.69	0.16	-0.19	0.21	-0.12	0.27
Non Current Liabilities Total	0.93	0.97	0.66	0.92	0.7	0.87	0.97	0.47	0.03	0.85	0.29	0.47	0.8	0.01		0.82	0.44	-0.31	0.98	0.86	0.43	0.85	0.42	0.93	0.03	0.8
Inventory	0.95	0.85	0.68	0.94	0.85	0.98	0.83	0.7	0.21	0.86	0.1	0.28	0.85	0.17	0.82		0.55	-0.23	0.91	0.91	0.53	0.78	0.15	0.88	0.04	0.84
Other Current Assets	0.45	0.42	0.57	0.43	0.36	0.48	0.43	0.18	-0.07	0.36	0.27	0.3	0.46	-0.21	0.44	0.55		-0.49	0.45	0.51	-0.09	0.5	0.32	0.35	-0.19	0.28
Other Stockholder Equity	-0.21	-0.31	-0.06	-0.19	0.15	-0.21	-0.35	0.36	0.38	0.01	0.13	-0.11	-0.1	0.81	-0.31	-0.23	-0.49		-0.25	-0.18	0.48	-0.11	-0.37	-0.2	-0.1	-0.11
Total Liab	0.98	0.98	0.67	0.99	0.78	0.95	0.96	0.58	0.16	0.9	0.23	0.42	0.86	0.12	0.98	0.91	0.45	-0.25		0.91	0.53	0.87	0.31	0.96	-0.02	0.88
Total Current Assets	0.93	0.81	0.68	0.91	0.79	0.91	0.78	0.6	0.28	0.78	0.4	0.62	0.9	0.15	0.86	0.91	0.51	-0.18	0.91		0.56	0.93	0.43	0.8	0.1	0.67
Common Stock	0.59	0.44	0.14	0.58	0.83	0.57	0.41	0.89	0.31	0.74	0.31	0.25	0.55	0.69	0.43	0.53	-0.09	0.48	0.53	0.56		0.49	0.02	0.57	0.04	0.61
Accounts Payable	0.85	0.77	0.7	0.85	0.68	0.81	0.73	0.48	0.38	0.72	0.4	0.65	0.89	0.16	0.85	0.78	0.5	-0.11	0.87	0.93	0.49		0.41	0.74	0.01	0.58
Short Term Investments	0.28	0.26	0.24	0.21	0.13	0.17	0.3	-0.09	-0.36	0.13	0.82	0.85	0.16	-0.19	0.42	0.15	0.32	-0.37	0.31	0.43	0.02	0.41		0.21	0.4	-0.05
Intangible Assets	0.96	0.97	0.57	0.96	0.81	0.92	0.96	0.65	0.05	0.93	0.15	0.25	0.77	0.21	0.93	0.88	0.35	-0.2	0.96	0.8	0.57	0.74	0.21		0.01	0.95
Current Deferred Revenue	0.02	-0.04	-0.14	-0.05	0.03	-0.04	-0.01	0.02	-0.22	-0.05	0.15	0.29	-0.05	-0.12	0.03	0.04	-0.19	-0.1	-0.02	0.1	0.04	0.01	0.4	0.01		-0.13
Short Term Debt	0.88	0.91	0.47	0.9	0.8	0.88	0.89	0.7	0.11	0.92	-0.05	0.02	0.69	0.27	0.8	0.84	0.28	-0.11	0.88	0.67	0.61	0.58	-0.05	0.95	-0.13

Click cells to compare fundamentals

Torrent Pharmaceuticals Account Relationship Matchups

Torrent Pharmaceuticals balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	140.4B	140.7B	131.0B	150.1B	150.6B	81.8B
Short Long Term Debt Total	58.4B	48.7B	40.7B	53.7B	40.2B	27.1B
Other Current Liab	8.1B	8.0B	7.4B	1.0B	8.1B	4.9B
Total Current Liabilities	54.8B	48.9B	44.2B	54.5B	54.3B	29.4B
Total Stockholder Equity	48.2B	58.4B	59.5B	62.0B	68.6B	72.0B
Property Plant And Equipment Net	35.3B	36.3B	32.5B	34.6B	35.8B	20.1B
Net Debt	51.8B	43.0B	36.7B	48.6B	31.9B	22.3B
Retained Earnings	18.9B	28.1B	29.2B	33.0B	39.4B	41.4B
Cash	6.6B	5.7B	4.0B	5.1B	8.4B	4.8B
Non Current Assets Total	90.3B	85.5B	79.3B	97.0B	94.5B	99.2B
Non Currrent Assets Other	2.6B	1.1B	3.2B	2.0B	9.0B	9.5B
Cash And Short Term Investments	6.6B	7.4B	5.8B	8.4B	10.0B	8.0B
Net Receivables	20.0B	18.9B	19.2B	19.5B	18.4B	12.3B
Liabilities And Stockholders Equity	140.4B	140.7B	131.0B	150.1B	150.6B	81.8B
Non Current Liabilities Total	37.3B	33.5B	27.3B	33.7B	27.8B	20.6B
Inventory	21.5B	26.8B	24.6B	22.3B	22.8B	13.3B
Other Current Assets	21.7B	21.0B	21.2B	3.0B	4.8B	8.4B
Total Liab	92.1B	82.4B	71.5B	88.1B	82.0B	50.0B
Total Current Assets	50.1B	55.2B	51.6B	53.1B	56.1B	35.6B
Accumulated Other Comprehensive Income	(12.4B)	29.4B	29.5B	27.3B	27.4B	28.8B
Accounts Payable	20.5B	20.7B	16.7B	16.8B	20.9B	15.0B
Short Term Investments	5M	1.7B	1.8B	3.3B	1.7B	1.6B
Intangible Assets	43.7B	39.8B	35.5B	50.9B	45.8B	23.9B
Current Deferred Revenue	(25.4B)	7.9B	7.3B	8.5B	45M	42.8M
Short Term Debt	25.5B	19.7B	19.5B	28.2B	23.5B	15.5B
Other Liab	3.2B	4.3B	3.8B	5.7B	6.6B	4.2B
Net Tangible Assets	(3.6B)	1.1B	15.1B	21.5B	19.3B	20.3B
Other Assets	6.9B	5.3B	6.8B	5.4B	6.3B	3.9B
Long Term Debt	32.8B	29.4B	21.2B	25.0B	16.0B	27.5B
Short Long Term Debt	25.1B	7.0B	19.0B	28.0B	23.3B	16.9B
Property Plant Equipment	35.3B	36.3B	32.5B	34.6B	39.8B	30.0B
Good Will	3.4B	3.4B	2.6B	3.4B	3.4B	3.0B
Long Term Debt Total	33.0B	29.6B	21.6B	25.5B	29.3B	31.8B
Non Current Liabilities Other	600K	50M	40M	20M	10M	9.5M
Cash And Equivalents	2.6B	149.3M	228.1M	379.8M	341.8M	324.7M
Net Invested Capital	106.1B	65.4B	99.7B	115.0B	107.9B	81.4B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Torrent Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Torrent Historical Balance Sheet

Torrent Pharmaceuticals Inventory

13.26 Billion

About Torrent Balance Sheet Analysis

Torrent Pharmaceuticals Balance Sheet Chart

Total Assets

Torrent Pharmaceuticals balance sheet Correlations

Torrent Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Torrent Pharmaceuticals balance sheet Accounts

Also Currently Popular

Other Information on Investing in Torrent Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 0.99	Total Assets
Net Debt	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Total Current Liabilities
Property Plant And Equipment Net	+ 0.98	Total Assets
Total Liab	+ 0.98	Total Assets
Total Liab	+ 0.98	Short Long Term Debt Total

Other Stockholder Equity	- 0.49	Other Current Assets
Short Term Investments	- 0.37	Other Stockholder Equity
Short Term Investments	- 0.36	Cash
Other Stockholder Equity	- 0.35	Net Debt
Other Stockholder Equity	- 0.31	Non Current Liabilities Total
Other Stockholder Equity	- 0.31	Short Long Term Debt Total